Literature DB >> 6143086

Eye drops of RU 486-6, a peripheral steroid blocker, lower intraocular pressure in rabbits.

C I Phillips, K Green, S M Gore, P M Cullen, M Campbell.   

Abstract

A peripheral corticosteroid blocker RU 486-6, instilled as a 1% suspension at random into one eye of 12 rabbits, produced a consistent fall in intraocular pressure as measured by a hand-held applanation tonometer, when compared with the fellow control eye. This or a similar drug may be applicable for treatment of human open-angle glaucoma, or ocular hypertension, by eliminating that part of ocular tension attributable to the effect on aqueous outflow of the normal and fluctuating level of tissue corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6143086     DOI: 10.1016/s0140-6736(84)91279-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

Review 1.  Corticosteroids and glaucoma risk.

Authors:  R C Tripathi; S K Parapuram; B J Tripathi; Y Zhong; K V Chalam
Journal:  Drugs Aging       Date:  1999-12       Impact factor: 3.923

Review 2.  Corticosteroid receptor antagonists: a current perspective.

Authors:  W Sutanto; E R de Kloet
Journal:  Pharm World Sci       Date:  1995-03-24

3.  Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats.

Authors:  Allyson A Gosling; Julie A Kiland; Lauren E Rutkowski; Adam Hoefs; Norman Matthew Ellinwood; Gillian J McLellan
Journal:  Vet Ophthalmol       Date:  2016-02-15       Impact factor: 1.644

4.  Subconjunctival suspension of RU486 lowers intraocular pressure in normal rabbits.

Authors:  S Tsukahara; T Sasaki; C I Phillips; S M Gore
Journal:  Br J Ophthalmol       Date:  1986-06       Impact factor: 4.638

5.  Experimental research on the relationship between the stiffness and the expressions of fibronectin proteins and adaptor proteins of rat trabecular meshwork cells.

Authors:  Chuan Wang; Lin Li; Zhicheng Liu
Journal:  BMC Ophthalmol       Date:  2017-12-29       Impact factor: 2.209

6.  Endogenous hypercortisolism inducing reversible ocular hypertension.

Authors:  Shane Griffin; Timothy Boyce; Beth Edmunds; William Hills; Marjorie Grafe; Shandiz Tehrani
Journal:  Am J Ophthalmol Case Rep       Date:  2019-11-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.